Entera Bio
ENTX
7 hedge funds and large institutions have $4.67M invested in Entera Bio in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
51% more capital invested
Capital invested by funds: $3.1M → $4.67M (+$1.57M)
17% more funds holding
Funds holding: 6 → 7 (+1)
0.52% more ownership
Funds ownership: 8.98% → 9.49% (+0.52%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
+$243K |
| 2 |
DAM
DLD Asset Management
New York
|
+$109K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$48.5K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $2.06M | – | – | – |
|
|
DAM
2
DLD Asset Management
New York
| $1.44M | +$109K | +26,900 | +9% |
|
|
WCM
3
Wildcat Capital Management
New York
| $853K | – | – | – |
|
|
CBA
4
Coastal Bridge Advisors
Westport,
Connecticut
| $249K | +$243K | +60,060 | New |
|
|
WVP
5
Worth Venture Partners
Fort Lee,
New Jersey
| $65K | -$48.5K | -11,998 | -45% |
|
|
6
UBS Group
Zurich,
Switzerland
| $5K | +$4.6K | +1,137 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4K | +$3.88K | +960 | +48,000% |
|
|
FIA
8
FNY Investment Advisers
New York
| – | -$46K | -15,189 | Closed |
|
ENTX Hedge Fund Activity: Q1 2019 in Review
7 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2019, worth a combined $4.67M — up 51% from $3.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ENTX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Coastal Bridge Advisors, opening a new position worth an estimated $243K. The largest seller was Worth Venture Partners, cutting an estimated $48.5K.
- 7 institutional investors held Entera Bio (ENTX) as of Q1 2019, up from 6 in Q4 2018.
- Funds reported $4.67M of Entera Bio stock for Q1 2019, up 51% quarter-over-quarter.
- 2 funds opened new Entera Bio positions in Q1 2019 and 1 closed out, a net change of +1 holder.
- The largest Entera Bio buyer in Q1 2019 was Coastal Bridge Advisors, an estimated $243K added.
- The largest Entera Bio seller in Q1 2019 was Worth Venture Partners, an estimated $48.5K sold.
Based on aggregated 13F filings for Q1 2019.